EZHIP and diffuse midline glioma: The H3K27M mutations in diffuse midline glioma (DMG) and EZHIP overexpression in ependymoma, while featuring increased levels of H3K27me3 at tumor suppressor genes such as CDKN2A, have broadly reduced levels of H3K27me3 and H3K27me2.